Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Matthew Frieman and Julie Dyall.
Matthew Frieman
Connection Strength
1.117
Julie Dyall
  1. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014 Aug; 58(8):4885-93.
    View in: PubMed
    Score: 0.582
  2. The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses. Proc Natl Acad Sci U S A. 2020 12 01; 117(48):30687-30698.
    View in: PubMed
    Score: 0.228
  3. Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies. Drugs. 2017 Dec; 77(18):1935-1966.
    View in: PubMed
    Score: 0.186
  4. MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells. PLoS One. 2018; 13(3):e0194868.
    View in: PubMed
    Score: 0.048
  5. Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrob Agents Chemother. 2015 Feb; 59(2):1088-99.
    View in: PubMed
    Score: 0.038
  6. Interferon-ß and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. J Gen Virol. 2014 Mar; 95(Pt 3):571-577.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.